BIOSIG TECHNOLOGIES, INC. (STEX)
Clinical trial NCT07110376 updates: 1. completion date: 2026-12-31 → 2027-03-31 2. primary completion date: 2026-07-01 → 2026-12-31
Clinical trial NCT07110376 updates: 1. completion date: 2026-12-31 → 2027-03-31 2. primary completion date: 2026-07-01 → 2026-12-31
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical